Prohibits certain steering and marketing practices involving dispensing of prescription drugs and drug samples.
S 1158 prohibits drug manufacturers, pharmacies, wholesalers, and healthcare practitioners from using devices, kiosks, or systems to steer patients to specific pharmacies or limit their pharmacy choice when dispensing prescription drugs or samples. It requires that any transmission of patient information to a pharmacy must be voluntary or accompanied by full disclosure of the patient's right to choose their pharmacy. Violations carry civil penalties: $100,000+ for companies and $250+ for practitioners per offense, collected by local health agencies. The bill directly affects healthcare providers, drug suppliers, and pharmacy systems that use technology for drug dispensing. It aims to protect patient autonomy in pharmacy selection while preventing misuse of patient data for marketing.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2024
Committee Review
Floor Vote
Governor
Introduced Jan 9, 2024
Last action Jan 9, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Jan 9, 2024
Introduced
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
upper
2 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about S 1158
Scope: NJ
Hi! I can help you understand S 1158. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline